WILMINGTON, Del., May 03, 2017 -- Navient (NASDAQ:NAVI) today announced that President and CEO Jack Remondi will speak at the Barclays Americas Select Franchise Conference on Tuesday, May 16. Remondi will deliver remarks at 3:40 p.m. BST (10:40 a.m. EDT) in London. A live audio webcast, along with any written materials or slides used during the presentation, will be available at Navient.com/investors. A replay will be available approximately two hours following the presentation through May 31.
About Navient
Navient (Nasdaq:NAVI) is a Fortune 500 company that provides asset management and business processing solutions to education, healthcare, and government clients at the federal, state, and local levels. The company helps its clients and millions of Americans achieve financial success through services and support. Headquartered in Wilmington, Del., Navient employs team members in western New York, northeastern Pennsylvania, Indiana, Tennessee, Texas, Virginia, and other locations. Learn more at navient.com.
Contact: Media: Nikki Lavoie, 302-283-4057, [email protected] Investors: Joe Fisher, 302-283-4075, [email protected]


Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 



